CVS Health is reportedly closing down a number of its pharmacies installed in Target stores in the United States. The pharmacies are expected to be removed from the discount department store chain’s locations in early 2024.
As per CNN Business, the spokesperson of CVS Health confirmed the closure of its drug stores on Thursday, Jan. 11. It was said that the decision to stop its operations inside the Target outlets comes as retail pharmacy companies in the U.S. are faced with growing difficulties with their workforce, prescriptions business, and other aspects.
Schedule of the Pharmacy Shut Downs
The American retail pharmacy brand said it will close its stores in Target locations from next month until April this year. The company also said this is part of its strategy to spread out its stores and pharmacies even more. This information was shared with CNN through an email from CVS Pharmacy’s spokesperson, Amy Thibault.
The closing of the pharmacies is “based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients,” the spokeswoman said.
Select Locations are Affected
Forbes reported that only select locations of Target stores are losing their CVS Health outlets this year. Then again, the company did not mention specific locations for the shutdown. The company is currently operating around 9,000 stores across the country.
“The pharmacy closures will begin in February and be completed by the end of April and impacted employees will be offered comparable roles within the company,” CVS Health said in a statement. “The closures are part of our plan to realign our national retail footprint and reduce store and pharmacy density and are based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients.”
Photo by: Marques Thomas/Unsplash


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 



